Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RIZAFILM safely and effectively. See full prescribing information for RIZAFILM. RIZAFILM (rizatriptan) oral film Initial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
RizaFilm™ is indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years of age. Limitations of Use RizaFilm should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with RizaFilm, the diagnosis of migraine should be reconsidered before RizaFilm is administered to treat any subsequent attacks. RizaFilm is not indicated for the preventive treatment of migraine. Safety and effectiveness of RizaFilm have not been established for cluster headache.
- generic_name
- rizatriptan benzoate
- product_names
- rizatriptan benzoate
- ndc
- 35781-0600, 35781-0605, 35781-0605-1, 35781-0605-8, 35781-0600-1, 35781-0600-8
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en